|
More site info...
Articles of Interest | Forum profile
|
|
Forum profile page for Articles of Interest on http://her2support.org.
This report page is the aggregated overview from a single forum: Articles of Interest, located on the Message Board at http://her2support.org.
This forum profile page summarizes the general forum statistics such as: Users Activity, Forum Activity, and Top Authors, which are reported in either a table or graph below for a given reporting time period.
Additional forum profile information for "Articles of Interest" on the Message Board at http://her2support.org is also shown in the following ways:
1) Latest Active Threads
2) Hot Threads for Last Week
Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a forum's popularity and/or exact posting volumes at any given reporting period.
|
|
|
|
|
Posting activity on Articles of Interest:
|
|
Week
|
Month
|
3 Months
|
|
Threads:
|
42
|
182
|
330
|
|
Post:
|
70
|
307
|
505
|
|
|
Articles of Interest Posting activity graph:
|
Top authors during last week:
user's latest post:
mTOR inhibitors
Published (2009-11-27 19:48:00)
Clin Cancer Res. 2009 Nov 24. [Epub ahead of print] Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells. Miller TW, Forbes JT, Shah C, Wyatt SK, Manning HC, Olivares MG, Sanchez V, Dugger TC, de Matos Granja N, Narasanna A, Cook RS, Kennedy JP, Lindsley CW, Arteaga CL. Authors' Affiliations: Departments of Medicine, Radiology and Radiological...
user's latest post:
Inhibiting LOX expression...
Published (2009-11-26 03:10:00)
Hi A lot of alternative practitioners recommend eating a diet rich in natural COX and LOX inhibiting foods.I suppose we are back to the whole question if synergy again? Ellie
user's latest post:
Trastuzumab Prolongs Survival in...
Published (2009-11-27 07:47:00)
This is a Medscape Article, and may require registration (free) to access: http://www.medscape.com/viewarticle/712967 Her2support's registration info: Username: Her2support Password: Member Hopeful
user's latest post:
Aloe
Published (2009-11-24 19:45:00)
Wow! I'm lovin' this!
|
|
|
|
Latest active threads on Articles of Interest::
Started 2 weeks, 2 days ago (2009-11-13 02:03:00)
by Rich66
mTOR inhibitors
J Hematol Oncol. 2009 Oct 27;2:45.
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.
Yuan R , Kay A , Berg WJ , Lebwohl D .
Novartis Oncology, Florham Park, NJ, USA. yuanru@umdnj.edu .
ABSTRACT: The mammalian target of rapamycin (mTOR) is an intracellular serine/threonine ...
Started 3 weeks, 1 day ago (2009-11-06 20:44:00)
by Rich66
Cancer Cell. 2009 Jan 6;15(1):35-44.
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Erler JT , Bennewith KL , Cox TR , Lang G , Bird D , Koong A , Le QT , Giaccia AJ .
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Tumor cell metastasis is facilitated by "...
Started 5 days, 10 hours ago (2009-11-23 19:07:00)
by Laurel
Interesting how an argument/research can be skewed so easily, isn't it? Why not use the form most readily available to the public and in doses commonly used by them? Doesn't make sense to me. Am I missing something here, Rich?
Started 6 days, 12 hours ago (2009-11-22 17:53:00)
by Rich66
Crit Rev Immunol. 2008;28(2):95-107.
Pathogen-associated molecular pattern in cancer immunotherapy.
Hobohm U , Stanford JL , Grange JM .
University of Applied Sciences, Bioinformatics, Wiesenstrasse 14, D-35390 Giessen, Germany. uwe.hobohm@tg.fh-giessen.de
Observations from different research frontiers--epidemiological data, case studies on spontaneous regressions from cancer, ...
Started 4 weeks ago (2009-11-01 02:29:00)
by Lani
Yes, I just heard Dr. Kerbel speak on a similar protocol at the San Diego conference I attended mid-October.
Among what he discussed:
Clin Cancer Res. 2009 Oct 15;15(20):6358-66. Epub 2009 Oct 13.
Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.
Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS....
Started 1 month ago (2009-10-27 13:45:00)
by Rich66
Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):1015-35. Epub 2007 Jul 4.
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
Lévi F , Focan C , Karaboué A , de la Valette V , Focan-Henrard D , Baron B , Kreutz F , Giacchetti S .
INSERM, U776 Rythmes biologiques et cancers, Hôpital Paul Brousse, Villejuif, F-94807, France. levi-f@...
|
|
Hot threads for last week on Articles of Interest::
Started 6 months ago (2009-05-27 02:20:00)
by Ellie F
Wonder if it's junk carbs that are the problem?? There has been an explosion in these post second world war with much more refined bread,cakes etc and less whole food carbs and chemical fertilisers on grain etc.?
Ellie
Started 1 week, 1 day ago (2009-11-21 01:32:00)
by Rich66
Neuropathy
Ann Pharmacother. 2008 Oct;42(10):1481-5. Epub 2008 Aug 12.
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S .
Pharmacy Department, Saint Barnabas Medical Center, 94 Old Short Hills Rd., Livingston, NJ 07039, USA. samara@sbhcs.com
OBJECTIVE: To evaluate the role of ...
Started 5 days, 10 hours ago (2009-11-23 19:07:00)
by Laurel
Interesting how an argument/research can be skewed so easily, isn't it? Why not use the form most readily available to the public and in doses commonly used by them? Doesn't make sense to me. Am I missing something here, Rich?
Started 1 week ago (2009-11-21 13:21:00)
by Rich66
Temporal concurrence of vasculitis and cancer: a report of 12 cases.
Arthritis Care Res. 2000 Dec;13(6):417-23.
Temporal concurrence of vasculitis and cancer: a report of 12 cases.
Hutson TE , Hoffman GS .
Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
OBJECTIVE: Vasculitis has been associated with ...
Started 4 weeks ago (2009-11-01 02:29:00)
by Lani
Yes, I just heard Dr. Kerbel speak on a similar protocol at the San Diego conference I attended mid-October.
Among what he discussed:
Clin Cancer Res. 2009 Oct 15;15(20):6358-66. Epub 2009 Oct 13.
Comparative impact of trastuzumab and cyclophosphamide on HER-2-positive human breast cancer xenografts.
Francia G, Man S, Lee CJ, Lee CR, Xu P, Mossoba ME, Emmenegger U, Medin JA, Kerbel RS....
Started 3 weeks, 1 day ago (2009-11-06 20:44:00)
by Rich66
Cancer Cell. 2009 Jan 6;15(1):35-44.
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.
Erler JT , Bennewith KL , Cox TR , Lang G , Bird D , Koong A , Le QT , Giaccia AJ .
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Tumor cell metastasis is facilitated by "...
Started 1 week ago (2009-11-21 12:58:00)
by Rich66
J Clin Oncol. 2006 Apr 20;24(12):1831-8. Epub 2006 Mar 20.
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer.
Hurley J , Doliny P , Reis I , Silva O , Gomez-Fernandez C , Velez P , Pauletti G , Powell JE , Pegram MD , Slamon DJ .
Sylvester Cancer Center, Miller School of ...
Started 1 week ago (2009-11-21 15:07:00)
by Rich66
Aloe
In Vivo. 2009 Jan-Feb;23(1):171-5.
A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.
Lissoni P , Rovelli F , Brivio F , Zago R , Colciago M , Messina G , Mora A , Porro G .
Division of Radiation Oncology, St. Gerardo Hospital, Monza, ...
Started 6 days, 12 hours ago (2009-11-22 17:53:00)
by Rich66
Crit Rev Immunol. 2008;28(2):95-107.
Pathogen-associated molecular pattern in cancer immunotherapy.
Hobohm U , Stanford JL , Grange JM .
University of Applied Sciences, Bioinformatics, Wiesenstrasse 14, D-35390 Giessen, Germany. uwe.hobohm@tg.fh-giessen.de
Observations from different research frontiers--epidemiological data, case studies on spontaneous regressions from cancer, ...
Started 1 week ago (2009-11-21 14:47:00)
by Rich66
Anti-prolactins
Anticancer Res. 2004 Nov-Dec;24(6):4223-6.
Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer.
Frontini L , Lissoni P , Vaghi M , Perego MS , Pescia S , Ardizzoia A , Gardani G .
Division of Radiation Oncology, ...
|
|
Size: 3,287 bytes
